Tianshui Zhongxing Bio-technologyLtd 대차 대조표 상태
재무 상태 기준 확인 4/6
Tianshui Zhongxing Bio-technologyLtd has a total shareholder equity of CN¥3.4B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 71.6%. Its total assets and total liabilities are CN¥6.3B and CN¥2.9B respectively. Tianshui Zhongxing Bio-technologyLtd's EBIT is CN¥89.0M making its interest coverage ratio 2.2. It has cash and short-term investments of CN¥1.6B.
주요 정보
71.6%
부채 비율
CN¥2.44b
부채
| 이자 보상 비율 | 2.2x |
| 현금 | CN¥1.63b |
| 주식 | CN¥3.41b |
| 총 부채 | CN¥2.90b |
| 총 자산 | CN¥6.31b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think
Nov 02
These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong
Oct 01Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30
May 12Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%
Mar 15재무 상태 분석
단기부채: 002772's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥1.4B).
장기 부채: 002772's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥1.5B).
부채 대 자본 내역 및 분석
부채 수준: 002772's net debt to equity ratio (23.6%) is considered satisfactory.
부채 감소: 002772's debt to equity ratio has reduced from 74.1% to 71.6% over the past 5 years.
부채 범위: 002772's debt is not well covered by operating cash flow (17.1%).
이자 보장: 002772's interest payments on its debt are not well covered by EBIT (2.2x coverage).